HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells.

Abstract
mda-7 is a novel tumor suppressor with cytokine properties. Adenoviral mda-7 (Ad-mda7) induces apoptosis and cell death selectively in tumor cells. The molecular mechanisms underlying the anti-tumor activity of Ad-mda7 in breast and lung cancer lines were investigated. Microarray analyses implicated both the beta-catenin and the PI3K signaling pathways. Ad-mda7 treatment increased protein expression from tumor suppressor genes, including E-cadherin, APC, GSK-3beta, and PTEN, and decreased expression of proto-oncogenes involved in beta-catenin and PI3K signaling. Ad-mda7 caused a redistribution of cellular beta-catenin from the nucleus to the plasma membrane, resulting in reduced TCF/LEF transcriptional activity, and upregulated the E-cadherin-beta-catenin adhesion complex in a tumor cell-specific manner. Expression of the PI3K pathway members (p85 PI3K, FAK, ILK-1, Akt, and PLC-gamma) was downregulated and expression of the PI3K antagonist PTEN was increased. Consistent with this result, pharmacological inhibition of PI3K by wortmannin did not abrogate killing by Ad-mda7. Killing of breast cancer cells by Ad-mda7 required both MAPK and MEK1/2 signaling pathways, whereas these pathways were not essential for MDA-7-mediated killing in lung cancer cells. Thus, in breast and lung tumor cells MDA-7 protein expression modulates cell-cell adhesion and intracellular signaling via coordinate regulation of the beta-catenin and PI3K pathways.
AuthorsAbner M Mhashilkar, Alexis L Stewart, Kerry Sieger, Heng-Yin Yang, Anis H Khimani, Isao Ito, Yuji Saito, Kelly K Hunt, Elizabeth A Grimm, Jack A Roth, Raymond E Meyn, Rajagopal Ramesh, Sunil Chada
JournalMolecular therapy : the journal of the American Society of Gene Therapy (Mol Ther) Vol. 8 Issue 2 Pg. 207-19 (Aug 2003) ISSN: 1525-0016 [Print] United States
PMID12907143 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • CTNNB1 protein, human
  • Cadherins
  • Cytoskeletal Proteins
  • Interleukins
  • Phosphoinositide-3 Kinase Inhibitors
  • Trans-Activators
  • beta Catenin
  • interleukin-24
Topics
  • Adenoviridae (genetics)
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Cadherins (metabolism)
  • Cell Adhesion
  • Cell Death
  • Cell Line, Tumor
  • Cell Movement
  • Cytoskeletal Proteins (antagonists & inhibitors, metabolism)
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Humans
  • Interleukins (genetics, metabolism)
  • Lung Neoplasms (genetics, metabolism, pathology)
  • Oligonucleotide Array Sequence Analysis
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Binding
  • Proto-Oncogenes (genetics)
  • Signal Transduction
  • Trans-Activators (antagonists & inhibitors, metabolism)
  • beta Catenin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: